Group One Trading, L.P. Repare Therapeutics Inc. Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$4.53 - $8.41 $18,305 - $33,984	-4,041 Reduced 34.6%	7,637 $35,000
Q4 2023 Feb 14, 2024	SELL	$3.22 - $11.79 $4,913 - $17,991	-1,526 Reduced 11.56%	11,678 $85,000
Q3 2023 Nov 09, 2023	BUY	$8.16 - $13.01 $102,285 - $163,080	12,535 Added 1873.69%	13,204 $159,000
Q2 2023 Aug 09, 2023	BUY	$8.63 - $12.53 $3,357 - $4,874	389 Added 138.93%	669 $7,000
Q1 2023 May 12, 2023	BUY	$9.32 - $15.06 $2,609 - $4,216	280 New	280 $2,000
Q3 2022 Nov 09, 2022	SELL	$11.57 - $15.59 $147,760 - $199,099	-12,771 Reduced 99.71%	37 $0
Q2 2022 Aug 11, 2022	BUY	$8.45 - $14.84 $108,227 - $190,070	12,808 New	12,808 $179,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $55.4M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.